DOI: 10.1515/mr-2022-0045
Immunotherapy prototype Mark 3.0 model in primary liver cancer:adding locoregional stereotactic therapy and prognostic factors classification management
Xu Yang
Nan Zhang
Yang Song
Xiaobo Yang
Xinting Sang
Haitao Zhao
Keywords：hepatocellular carcinomaimmune checkpoint inhibitorsprimary liver cancerprognostic factorspro-grammed cell death-1stereotactic therapy
Publication Date：2022-12-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 547-552 )